Aligos Therapeutics ALGS Balance Sheet (2019-2026)

NASDAQ ALGS
$6.44 -0.45 (-6.53%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
239.73M186.82M104.56M71.17M86.44M81.35M78.67M90.83M70.43M135.70M112.70M94.50M74.90M37.00M137.90M122.90M99.10M18.30M54.90M30.40M
Short-term Investments (Quarter)
0.65M0.20M78.66M0.02M0.08M44.48M0.40M0.04M0.07M0.10M0.22M0.07M39.59M19.94M0.11M104.28M0.11M0.11M24.93M0.04M
Cash & Current Investments (Quarter)
240.39M187.02M183.22M71.19M86.52M125.83M79.07M90.87M70.50M135.80M112.92M94.57M114.49M56.94M138.01M227.18M99.21M18.41M79.83M30.44M
Prepaid Assets (Quarter)
3.93M
Receivables - Net (Quarter)
27.78M
Receivables (Quarter)
27.78M
Current Assets (Quarter)
62.13M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
1.33M
Long-Term Investments (Quarter)
0.49M15.11M
Other Non-Current Assets (Quarter)
0.76M
Non-Current Assets (Quarter)
4.20M
Assets (Quarter)
66.33M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
6.43M
Payables (Quarter)
6.43M
Accumulated Expenses (Quarter)
18.70M
Other Accumulated Expenses (Quarter)
7.03M
Current Leases (Quarter)
3.15M
Current Deferred Revenue (Quarter)
6.64M7.64M15.07M13.13M10.72M8.74M6.56M4.10M2.09M1.31M0.15M0.58M0.17M
Total Current Liabilities (Quarter)
28.34M
Non-Current Liabilities
Capital Leases (Quarter)
0.05M0.26M0.23M0.20M0.17M0.23M0.20M0.20M0.19M0.23M0.22M0.20M0.19M0.12M0.12M0.12M0.12M
Non-Current Deffered Revenue (Quarter)
1.37M5.01M3.25M1.56M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
0.29M
Other Non-Current Liabilities (Quarter)
0.27M0.13M0.13M0.13M0.13M27.60M41.97M11.49M11.60M72.37M
Total Non-Current Liabilities (Quarter)
45.79M50.51M57.45M45.41M41.92M31.85M26.14M30.09M26.73M26.70M
Total Liabilities (Quarter)
34.44M
Shareholder's Equity
Common Equity (Quarter)
31.88M
Liabilities and Shareholders Equity (Quarter)
66.33M
Retained Earnings (Quarter)
-666.75M
Treasury Shares (Quarter)
0.08M